glp-1 receptor agonist blood pressure reduction Frontiers GLP-1 and Low Blood Pressure:

J Clin Endocrinol Metab (2020) 105(8):e2695709

With A-listers like Chelsea Handler and Elon Musk giving it the red-carpet treatment, semaglutide is a headlining act you don't want to miss

1) Cancer and Thyroid Concerns Semaglutide is also not recommended for people with a family or medical history of medullary thyroid carcinoma (MTC), medullary thyroid cancer, and thyroid tumors or those with Multiple Endocrine Neoplasia syndrome type 2

In the context of simultaneous GLP-1 activation and caloric restriction, GIP might help mobilize fat stores more effectively or prevent metabolic adaptations that normally fight weight loss

doi: 10.1046/j.1365-201X.1996.42256000.x

doi: 10.1210/endo.130.5.1374016